Trikafta is now approved for use in CF patients 12 years and older with at least one F508del mutation.
Category: Forbes
Microsoft, Humana Partner To ‘Reimagine’ Healthcare For Aging Boomers
Microsoft and Humana are partnering in an effort to improve health outcomes of the health insurer’s subscribers by making their “health care experiences simpler to navigate,” the companies said.